Not yet recruiting NCT07381153

In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs

— Observational Cytotoxicity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Cytotoxicity. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Egypt
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Cytotoxicity Evaluation of INOX (Nanoksa G Plus) High-Performance Polymer Discs on Cell Cultures: An In-Vitro Experimental Study

Overview

This study aims to evaluate the cytotoxicity of INOX (Nanoksa G Plus) high-performance polymer discs on cell cultures using standardized in-vitro assays. The primary objective is to assess cell viability after exposure to INOX extracts. Secondary objectives include examining cell membrane integrity, cellular morphology, comparing effects across extract concentrations, and determining whether INOX meets accepted non-cytotoxicity standards.

Primary outcome measures

Cell viability [Time frame: JANUARY 2026]

Eligibility criteria

Inclusion criteria

To assess cell viability following exposure to INOX material extracts using a quantitative cell viability assay.

Exclusion criteria

To evaluate cell membrane integrity following exposure to INOX extracts. To assess cellular morphology after exposure to the material. To compare cytotoxic effects at different extract concentrations. To determine whether INOX meets accepted non-cytotoxicity thresholds.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model: Other

Study locations

Egypt · 1 center

Cairo university — Giza

Identifiers

NCT: NCT07381153 · 12l2025

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗